Tag Archives: NeuroNova

The Vision Thing

Putting all of one’s corporate chips on a single therapeutic program is seldom, if ever, a wise strategy. Even if the product moves forward, a company’s longterm viability depends on a periodically replenished pipeline. While this is a well-documented dynamic … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

Two CNS Acquisitions

Two companies had buyouts announced today: One is clearly good news, the second may be good for shareholders, we are not sure about the ramifications for its CNS work. 1) Newron is acquiring neurogenesis-specialist NeuroNova for about $20 million in … Continue reading

Posted in Uncategorized | Tagged , , , , , | Leave a comment